Healthcare Innovations, 3
Back to All Secondary TrustsPortfolio Holdings by Security (As of Deposit Date)
Ticker | Security Description | Deposit % |
---|---|---|
ACAD | ACADIA Pharmaceuticals Inc. | 3.15 |
ACOR | Acorda Therapeutics, Inc. | 2.05 |
AERI | Aerie Pharmaceuticals, Inc. | 3.10 |
AGIO | Agios Pharmaceuticals, Inc. | 3.71 |
ALDR | Alder BioPharmaceuticals, Inc. | 3.11 |
ALNY | Alnylam Pharmaceuticals, Inc. | 3.51 |
ALXN | Alexion Pharmaceuticals, Inc. | 3.22 |
ARRY | Array BioPharma Inc. | 2.68 |
AXON | Axovant Sciences Ltd. | 5.57 |
BLUE | bluebird bio, Inc. | 3.53 |
CLVS | Clovis Oncology, Inc. | 3.20 |
DBVT | DBV Technologies S.A. | 3.06 |
DERM | Dermira, Inc. | 3.35 |
FGEN | FibroGen, Inc. | 3.41 |
GLPG | Galapagos NV | 4.11 |
GWPH | GW Pharmaceuticals plc | 3.24 |
HZNP | Horizon Pharma plc | 3.43 |
INCY | Incyte Corporation | 2.92 |
IRWD | Ironwood Pharmaceuticals, Inc. | 3.13 |
JAZZ | Jazz Pharmaceuticals plc | 3.93 |
KITE | Kite Pharma, Inc. | 3.46 |
MDCO | Medicines Company | 3.58 |
ONCE | Spark Therapeutics, Inc. | 3.26 |
OPHT | Ophthotech Corporation | 2.72 |
PBYI | Puma Biotechnology, Inc. | 3.45 |
PCRX | Pacira Pharmaceuticals, Inc. | 3.37 |
RARE | Ultragenyx Pharmaceutical Inc. | 2.47 |
VRTX | Vertex Pharmaceuticals Incorporated | 4.26 |
VRX | Valeant Pharmaceuticals International, Inc. | 2.68 |
XLRN | Acceleron Pharma Inc. | 3.34 |
Health Care
Ticker | Security Description | Deposit % |
---|---|---|
ACAD | ACADIA Pharmaceuticals Inc. | 3.15 |
XLRN | Acceleron Pharma Inc. | 3.34 |
ACOR | Acorda Therapeutics, Inc. | 2.05 |
AERI | Aerie Pharmaceuticals, Inc. | 3.10 |
AGIO | Agios Pharmaceuticals, Inc. | 3.71 |
ALDR | Alder BioPharmaceuticals, Inc. | 3.11 |
ALXN | Alexion Pharmaceuticals, Inc. | 3.22 |
ALNY | Alnylam Pharmaceuticals, Inc. | 3.51 |
ARRY | Array BioPharma Inc. | 2.68 |
AXON | Axovant Sciences Ltd. | 5.57 |
BLUE | bluebird bio, Inc. | 3.53 |
CLVS | Clovis Oncology, Inc. | 3.20 |
DBVT | DBV Technologies S.A. | 3.06 |
DERM | Dermira, Inc. | 3.35 |
FGEN | FibroGen, Inc. | 3.41 |
GLPG | Galapagos NV | 4.11 |
GWPH | GW Pharmaceuticals plc | 3.24 |
HZNP | Horizon Pharma plc | 3.43 |
INCY | Incyte Corporation | 2.92 |
IRWD | Ironwood Pharmaceuticals, Inc. | 3.13 |
JAZZ | Jazz Pharmaceuticals plc | 3.93 |
KITE | Kite Pharma, Inc. | 3.46 |
MDCO | Medicines Company | 3.58 |
OPHT | Ophthotech Corporation | 2.72 |
PCRX | Pacira Pharmaceuticals, Inc. | 3.37 |
PBYI | Puma Biotechnology, Inc. | 3.45 |
ONCE | Spark Therapeutics, Inc. | 3.26 |
RARE | Ultragenyx Pharmaceutical Inc. | 2.47 |
VRX | Valeant Pharmaceuticals International, Inc. | 2.68 |
VRTX | Vertex Pharmaceuticals Incorporated | 4.26 |
Summary
Description
-
Trust Name Healthcare Innovations, 3
-
Trust Symbol SMHCCX
Deposit Data
-
Deposit Date 05/02/2017
-
Termination Date 20190502
-
Minimum Investment 100
-
Distribution Frequency Monthly (if any)
-
Initial Public Offer Price $10.00
-
Historical 12-Month Dist.* 0.0000
CUSIP
-
Cash Cusip 83186Y107
-
Reinvest Cusip 83186Y115
-
Fee Cash Cusip 83186Y123
-
Fee Invest Cusip 83186Y131
Documents
*The Historical 12-Month Distribution of Trust Holdings is as of 10/01/2024. If the Trust deposited after, or 90 days prior to, 10/01/2024, the distribution is as of deposit date. The Historical 12-Month Distribution is calculated by taking the weighted average of the regular income distributions paid by the securities included in the trust’s portfolio over the 12 months preceding the trust’s date of deposit reduced to account for the effects of trust fees and expenses. This historical distribution is for illustrative purposes only and is not indicative of amounts that will actually be distributed by the trust. The distributions paid by the trust may be higher or lower than the amount shown above due to factors including, but not limited to, changes in the price of trust units, changes (including reductions) in distributions paid by issuers, changes in actual trust expenses and sales of securities in the portfolio. There is no guarantee that the issuers of the securities included in the trust will pay any distributions in the future.